GlassScriptPhysician profile
Jonathan Lee Go
NPI 1902332349
$2,834.86
in general payments reported to CMS, 2019-2025
19 companies · $672 in 2025
The $672 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $633 · 2022: $299 · 2023: $571 · 2024: $660 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,902.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $478.75 | 2021-2025 | Clareon Panoptix Pro, Clareon, Rocklatan |
| Horizon Therapeutics Plc | $382.57 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $288.21 | 2021-2025 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $250.43 | 2021-2023 | Tecnis Iol, Tecnis Iol |
| Rxsight INC | $190.16 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Tarsus Pharmaceuticals, INC. | $182.38 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $178.87 | 2022-2025 | Xiidra, Miebo, Infuse |
| Harrow Eye, LLC | $136.72 | 2025 | Vevye |
| Apellis Pharmaceuticals, INC. | $127.75 | 2024 | |
| Biotissue Holdings INC. | $123.69 | 2022-2025 | |
| Astellas Pharma US INC | $118.96 | 2024 | Izervay |
| Mallinckrodt Hospital Products INC. | $92.99 | 2021 | |
| Oyster Point Pharma, INC. | $81.30 | 2023-2025 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $54.11 | 2021 | |
| Thea Pharma INC. | $43.51 | 2023 | Iyuzeh |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $34.11 | 2024 | |
| Nova Eye, INC. | $31.45 | 2025 | |
| Sight Sciences, INC. | $25.47 | 2024 | Omni Surgical System |
| Eyevance Pharmaceuticals LLC | $13.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Go listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.